73 related articles for article (PubMed ID: 27091869)
1. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
2. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
[TBL] [Abstract][Full Text] [Related]
3. Indication of acid suppression therapy and predictors for the prophylactic use of protonpump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital.
Oh AL; Tan AG; Phan HS; Lee BC; Jumaat N; Chew SP; Wong SH; Ting SH; Subramaniam T
Pharm Pract (Granada); 2015; 13(3):633. PubMed ID: 26445624
[TBL] [Abstract][Full Text] [Related]
4. The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.
Fan W; Liu H; Shen Y; Hong K
Cardiovasc Drugs Ther; 2024 Jun; 38(3):517-525. PubMed ID: 36625987
[TBL] [Abstract][Full Text] [Related]
5. Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study.
Murofushi T; Yagi T; Tsuji D; Furushima D; Fujikura T; Itoh K; Kawakami J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4927-4938. PubMed ID: 38170305
[TBL] [Abstract][Full Text] [Related]
6. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti-ulcer drugs on delirium in trauma patients.
Sogawa R; Matsuoka A; Murakawa-Hirachi T; Kikkawa N; Kamo M; Tobita S; Shinada K; Mizoguchi Y; Monji A; Sakamoto Y; Shimanoe C
Gen Hosp Psychiatry; 2023; 80():43-47. PubMed ID: 36587448
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.
Maret-Ouda J; Panula J; Santoni G; Xie S; Lagergren J
J Gastroenterol; 2023 Aug; 58(8):734-740. PubMed ID: 37314495
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and factors associated with inappropriate continuation of stress ulcer prophylaxis at discharge.
Chinnappan J; Al-Handola R; Joseph NM; Ogbon E; McDonald PJ
BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38729753
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of the effect of acid-suppressant therapy on clinicopathologic parameters of cats with chronic kidney disease.
Gould E; Klos J; Price J; Harris T; Vaden S; Tolbert MK
J Feline Med Surg; 2018 Jun; 20(6):520-527. PubMed ID: 28703633
[TBL] [Abstract][Full Text] [Related]
13. Association Between Acid-Suppressive Drugs and Risk of Rosacea: Retrospective Study Using the Korean National Health Insurance Service-National Sample Cohort.
Kim JH; Min JH; Jo YW; Kwon JW; Her Y
J Korean Med Sci; 2023 Dec; 38(47):e402. PubMed ID: 38050914
[TBL] [Abstract][Full Text] [Related]
14. Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.
Huang CH; Tseng YH; Tsai WS; Su CC; Cheng CL; Kao Yang YH; Chang YC; Liu YH
Infect Dis Ther; 2024 Feb; 13(2):373-383. PubMed ID: 38286955
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection.
Al-Momani H; Aolaymat I
Ann Med; 2024 Dec; 56(1):2355581. PubMed ID: 38823421
[TBL] [Abstract][Full Text] [Related]
16. Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea.
Weiss K; Louie T; Miller MA; Mullane K; Crook DW; Gorbach SL
BMJ Open Gastroenterol; 2015; 2(1):e000028. PubMed ID: 26462279
[TBL] [Abstract][Full Text] [Related]
17. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.
Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A
J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433
[TBL] [Abstract][Full Text] [Related]
18. Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.
Arinze JT; de Ridder MAJ; Vojinovic D; van Ballegooijen H; Markov E; Duarte-Salles T; Rijnbeek P; Verhamme KMC
Drug Saf; 2023 Dec; 46(12):1353-1362. PubMed ID: 37907775
[TBL] [Abstract][Full Text] [Related]
19. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.
Madej J; Atanassova T; McGuire S; Cohen B; Weidner M; Zhang Y; Horton DB
Pediatr Allergy Immunol; 2023 Nov; 34(11):e14042. PubMed ID: 38010007
[TBL] [Abstract][Full Text] [Related]
20. Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank.
Fan X; Liu Z; Miyata T; Dasarathy S; Rotroff DM; Wu X; Poulsen KL; Nagy LE
Gastroenterology; 2021 Jan; 160(1):455-458.e5. PubMed ID: 32980342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
